reglab/housing_qa huggingface dataset:
CT Gen Stat § 20-607. (Formerly Sec. 20-173) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-607. (Formerly Sec. 20-173) - Certificate of license, temporary permit or registration to be available for inspection.

 Each person practicing as a pharmacist, pharmacy intern or pharmacy technician shall at all times have available for inspection by an inspector of the department a current certificate of license or temporary permit to practice pharmacy or a current registration to act as a pharmacy intern or pharmacy technician.(1949 Rev., S. 4477; P.A. 95-264, S. 29; P.A. 98-31, S. 7; P.A. 99-175, S. 33; P.A. 00-182, S. 11.)History: P.A. 95-264 deleted reference to licensed or assistant pharmacist, deleted requirement that pharmacist must display certificate in the place he practices and required that a current certificate of license to practice must be available for inspection at all times; Sec. 20-173 transferred to Sec. 20-607 in 1997; P.A. 98-31 added provisions re pharmacy interns and pharmacy technicians; P.A. 99-175 made a technical change; P.A. 00-182 added “or temporary permit”.
CT Gen Stat § 20-608. (Formerly Sec. 20-174) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-608. (Formerly Sec. 20-174) - Use of certificate of license, temporary permit or display document by unlicensed person prohibited.

 A pharmacist who permits such pharmacist's certificate of license, temporary permit or display document to be used by an unlicensed person for unlawful use shall be fined one hundred dollars and shall be subject to other disciplinary proceedings within the authority of the commission.(1949 Rev., S. 4478; P.A. 95-264, S. 30; P.A. 99-175, S. 34; P.A. 00-182, S. 12.)History: P.A. 95-264 deleted reference to licensed or assistant pharmacist, made prohibition applicable to a display document, eliminated forfeiture as a penalty and substituted disciplinary proceedings as a penalty; Sec. 20-174 transferred to Sec. 20-608 in 1997; P.A. 99-175 made technical and gender neutral changes; P.A. 00-182 added language re temporary permit.See Sec. 19a-70 re violation of regulations governing distribution of biologic products during an emergency as grounds for suspension, revocation or annulment of a license or certificate.See Sec. 30-101 re forfeiture of liquor permit and pharmacist's license for allowing on-premises consumption of alcohol.
CT Gen Stat § 20-609. (Formerly Sec. 20-184) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-609. (Formerly Sec. 20-184) - Pharmacy license to be posted. Business which is not a pharmacy prohibited from using words, displays or symbols indicating it is a pharmacy; exemption.

 (a) A pharmacy license shall be conspicuously posted within the pharmacy.(b) Any person owning, managing or conducting any store, shop or place of business not being a pharmacy who exhibits within or upon the outside of such store, shop or place of business, or includes in any advertisement the words “drug store”, “pharmacy”, “apothecary”, “drug”, “drugs” or “medicine shop” or any combination of such terms or any other words, displays or symbols indicating that such store, shop or place of business is a pharmacy shall be guilty of a class D misdemeanor. The provisions of this subsection shall not apply to any person that provides pharmacy-related services directly to pharmacies or practitioners and does not offer such services and drugs or medical services directly to the public.(1949 Rev., S. 4485; P.A. 95-264, S. 31; P.A. 07-252, S. 74; P.A. 08-184, S. 29; P.A. 12-80, S. 71.)History: P.A. 95-264 inserted provisions as Subsec. (a) requiring pharmacy license to be posted in pharmacy, designated previous provisions as Subsec. (b), clarified the prohibition on use of specified terms, displays or symbols and deleted obsolete provisions prohibiting the use of show bottles and globes; Sec. 20-184 transferred to Sec. 20-609 in 1997; P.A. 07-252 amended Subsec. (b) to exempt from provisions persons who provide pharmacy-related services directly to pharmacies or practitioners and who do not offer drugs or pharmacy or medical services directly to the public; P.A. 08-184 made a technical change in Subsec. (b); P.A. 12-80 amended Subsec. (b) to replace penalty of a fine of not more than $200 or imprisonment of not more than 30 days or both with a class D misdemeanor and make technical changes.Annotation to former section 20-184:Cited. 141 C. 288.
CT Gen Stat § 20-611. (Formerly Sec. 20-175b) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-611. (Formerly Sec. 20-175b) - Advertising legend drug prices.

 A pharmacist or any person holding a pharmacy license (1) may advertise the price of any legend drug sold at retail based on the prescription of a prescribing practitioner, provided, each such advertisement shall clearly state the period during which the advertised price or prices shall remain in effect and shall not contain any statement indicating that the advertised price or prices are subject to change without notice; and (2) shall disclose, upon request, the price of any such legend drug to any prospective purchaser.(P.A. 75-95, S. 1, 3; P.A. 95-264, S. 33.)History: P.A. 95-264 made technical changes and changed references to “drug, medicine or chemical” to “legend drug”; Sec. 20-175b transferred to Sec. 20-611 in 1997.See chapter 418 re Uniform Food, Drug and Cosmetic Act.See chapter 419 re retail drug control.
CT Gen Stat § 20-612 (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-612 - Only pharmacy may accept prescription for dispensing.

 Subject to the provisions of subsection (f) of section 20-614, only a pharmacy shall accept a prescription for dispensing. No employee, personnel or owner of a place of business or establishment not licensed as a pharmacy may accept a prescription for transfer to or for collection for a pharmacy.(P.A. 95-264, S. 35; P.A. 04-107, S. 2; P.A. 19-191, S. 2.)History: P.A. 04-107 amended section so as to make it subject to the provisions of Sec. 20-614(d), which provides for electronic data intermediaries; P.A. 19-191 changed reference from Sec. 20-614(d) to Sec. 20-614(f).
CT Gen Stat § 20-612a (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-612a - Confirmation of identification prior to release of controlled substance. Exceptions.

 A pharmacist licensed pursuant to this chapter or his or her agent shall require the presentation of valid photographic identification prior to releasing a controlled substance to any person not known to such pharmacist. The provisions of this section shall not apply in an institutional setting or to a long-term care facility, including, but not limited to, an assisted living facility or a hospital.(P.A. 06-155, S. 3.)
CT Gen Stat § 20-613a (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-613a - Requests for controlled substance issued on results of answers to electronic questionnaire. Regulations.

 In the absence of a documented patient evaluation that includes a physical examination, any request for a controlled substance issued solely on the results of answers to an electronic questionnaire shall be considered to be issued outside the context of a valid practitioner-patient relationship and not be a valid prescription. The Commissioner of Consumer Protection may adopt regulations, in accordance with chapter 54, concerning such requests for controlled substances. For the purposes of this section, “electronic questionnaire” means any form in an electronic format that may require personal, financial or medical information from a consumer or patient.(P.A. 05-73, S. 3.)History: P.A. 05-73 effective May 31, 2005.
CT Gen Stat § 20-616a (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-616a - Prescription refills for quantity of drug greater than initial quantity prescribed. Conditions.

 A pharmacist may exercise his or her professional judgment in refilling a prescription for a quantity of a drug greater than the initial quantity of a drug prescribed by the prescribing practitioner, provided (1) such refill is made after the patient's initial prescription is dispensed, (2) such refill does not exceed a ninety-day supply of such drug and does not exceed the total quantity of such drug authorized by the prescribing practitioner, (3) the prescribing practitioner has not indicated that the initial quantity or refill quantity of the prescribed drug shall not be changed, (4) such drug is not a controlled drug, as defined in section 21a-240, (5) the pharmacist informs the prescribing practitioner of such refill at the earliest reasonable time, but not later than forty-eight hours after such refill is made, and (6) the patient's health insurance policy or health benefit plan, if any, will cover the refill quantity dispensed, without additional coinsurance, deductible or other out-of-pocket expense required from the patient.(P.A. 15-116, S. 1.)History: P.A. 15-116 effective July 1, 2015.
CT Gen Stat § 20-617. (Formerly Sec. 20-184e) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-617. (Formerly Sec. 20-184e) - Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions.

 (a) Each pharmacist shall include on the label of each prescription container: (1) The quantity of prescribed drug placed in such container, in addition to any other information required by law, and (2) a prominently printed expiration date based on the manufacturer's recommended conditions of use and storage that can be read and understood by the ordinary individual. The expiration date required pursuant to subdivision (2) of this subsection shall be no later than the expiration date determined by the manufacturer.(b) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (c) of this section, each pharmacist shall include on the label of each prescription container or on the receipt or other similar packaging in which the prescription is contained for a drug sold only by generic name, as defined in section 20-14a, and not by brand name, as defined in said section: (1) The name of the manufacturer of the generic drug placed in the container, and (2) the Internet web site address and toll-free telephone number for the United States Food and Drug Administration's safety information and adverse event reporting program (MedWatch).(c) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (b) of this section, if a pharmacist substitutes a generic name drug for a brand name drug, such pharmacist shall include on the label of the prescription container: (1) The name of the generic drug placed in the container, and (2) the brand name of the drug that the generic drug was substituted for.(P.A. 93-94; P.A. 99-49; 99-175, S. 38; P.A. 00-182, S. 3; P.A. 15-219, S. 1.)History: Sec. 20-184e transferred to Sec. 20-617 in 1997; P.A. 99-49 made a technical change, added Subdiv. indicators and added provision requiring prescription drug container label to include drug's expiration date; P.A. 99-175 made technical changes and deleted reference to Sec. 20-590; P.A. 00-182 added language re manufacturer's recommended conditions of use and storage and deleted language re customary conditions of purchase, and use and storage and re absence of contrary data; P.A. 15-219 designated existing provisions as Subsec. (a), added Subsec. (b) re inclusion on label of name of manufacturer of generic drug and MedWatch program information, added Subsec. (c) re required label information for generic substitutes, and made technical changes, effective January 1, 2016.
CT Gen Stat § 20-617a (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-617a - Flavoring agent added to prescription product.

 (a) For purposes of this section, “flavoring agent” means an additive used in food or drugs when such additive: (1) Is used in accordance with good manufacturing practice principles and in the minimum quantity required to produce its intended effect, (2) consists of one or more ingredients generally recognized as safe in food and drugs, has been previously sanctioned for use in food and drugs by the state or the federal government, meets United States Pharmacopeia standards or is an additive permitted for direct addition to food for human consumption pursuant to 21 CFR 172, (3) is inert and produces no effect other than the instillation or modification of flavor, and (4) is not greater than five per cent of the total weight of the product.(b) A flavoring agent may be added to a prescription product by: (1) A pharmacist upon the request of the prescribing practitioner, patient for whom the prescription is ordered or such patient's agent, or (2) a pharmacist acting on behalf of a hospital, as defined in section 19a-490.(P.A. 12-12, S. 1.)History: P.A. 12-12 effective July 1, 2012.
CT Gen Stat § 20-618. (Formerly Sec. 21a-107) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-618. (Formerly Sec. 21a-107) - Repackaged drugs not considered misbranded, when.

 Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.(P.A. 79-116, S. 2; P.A. 95-264, S. 39.)History: Sec. 19-226a transferred to Sec. 21a-107 in 1983; P.A. 95-264 made technical changes; Sec. 21a-107 transferred to Sec. 20-618 in 1997.
CT Gen Stat § 20-619a (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-619a - Biological product prescribing. Prescribing practitioner discussion with patient or representative. Documentation. Patient request to sign for delivery.

 (a) Prior to prescribing a biological product, as defined in section 20-619, a prescribing practitioner shall discuss with the patient or a representative of the patient the treatment methods, alternatives to and risks associated with the use of such biological product. The prescribing practitioner shall inform the patient that he or she may opt to sign for delivery of the biological product. The prescribing practitioner shall document such discussion in the patient's medical record not later than twenty-four hours after such discussion has taken place. This section shall not apply to hospital inpatients, emergency care, F.D.A. approved vaccines, blood or blood components.(b) The patient or a representative of the patient may make a request of the pharmacy that the patient or representative be present to sign for delivery of the interchangeable biological product. The patient or representative of the patient may rescind such request at any time by notifying the pharmacy of such rescission.(P.A. 18-74, S. 2.)
CT Gen Stat § 20-621. (Formerly Sec. 20-185h) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-621. (Formerly Sec. 20-185h) - Relabeling and dispensing of parenteral medication in hospital and nursing home pharmacies: When allowed.

 A pharmacist practicing in a hospital pharmacy or nursing home pharmacy may relabel and dispense to a registered inpatient, parenteral medication, except controlled substances, dispensed for another registered patient by a licensed pharmacy if the following requirements are met: (1) The original medication order for the drug is discontinued; (2) the medication is in an unopened tamper-evident package; (3) the medication is not expired; (4) the original patient is not charged for the medication; and (5) upon receipt of the medication by the facility from the licensed pharmacy, it is processed through the hospital's pharmacy or nursing home pharmacy.(P.A. 93-173, S. 1.)History: Sec. 20-185h transferred to Sec. 20-621 in 1997.
CT Gen Stat § 20-622. (Formerly Sec. 20-180a) (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-622. (Formerly Sec. 20-180a) - Licensed practitioners may authorize medication to be dispensed from a hospital emergency room.

 When the therapeutic needs of a patient require that medication be initiated immediately and the services of a licensed pharmacy are not available within a five-mile radius of a hospital emergency room, a person associated with such hospital authorized to dispense medication may dispense up to a twenty-four-hour supply of medication, excluding controlled substances, to such patient. Such dispensing shall be authorized by a verbal order of a licensed practitioner. For purposes of this section, “licensed practitioner” means a physician on the staff of such hospital or other prescribing practitioner associated with such hospital who has examined such patient and determined the patient's therapeutic needs.(P.A. 93-173, S. 2; P.A. 99-175, S. 40.)History: Sec. 20-180a transferred to Sec. 20-622 in 1997; P.A. 99-175 made technical and gender neutral changes and deleted reference to Sec. 20-184a.
CT Gen Stat § 20-623 (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-623 - Sale of nonlegend drugs. Labels, packaging and contents. Penalty.

 (a) No nonlegend drug may be sold at retail except at a pharmacy or at a store that has obtained from the commission a permit to sell nonlegend drugs. Nonlegend drugs shall be labeled and packaged in accordance with state and federal law.(b) Any person who violates any provision of this section shall be fined not less than one hundred dollars nor more than five hundred dollars.(P.A. 95-264, S. 42; P.A. 99-175, S. 41.)History: P.A. 99-175 made a technical change in Subsec. (a).
CT Gen Stat § 20-624 (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-624 - Permit to sell nonlegend drugs.

 (a) Any person may apply to the commission for a permit to sell nonlegend drugs.(b) The commission may, in accordance with regulations adopted under sections 20-570 to 20-630, inclusive, in accordance with chapter 54, and on payment of the fee required in section 20-601, issue to an applicant a permit to sell nonlegend drugs for one year.(c) A permit that has expired under this section may be renewed, on application and payment of the renewal fee and any late fee required in section 20-601.(d) The holder of a permit to sell nonlegend drugs shall notify the commission of a change of ownership, name or location of the permit premises. Any holder who fails to notify the commission of such change within five days of the change shall pay the late fee required in section 20-601.(e) Any nonlegend drug permit issued by the commission pursuant to this section is nontransferable.(P.A. 95-264, S. 43; P.A. 99-175, S. 42.)History: P.A. 99-175 amended Subsec. (b) to replace reference to Sec. 20-625 with reference to Sec. 20-630 and add provision requiring adoption of regulations to be consistent with chapter 54 and added new Subsec. (e) to specify that nonlegend drug permits issued by commission are nontransferable.
CT Gen Stat § 20-625 (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-625 - Nonlegend veterinary drugs.

 Nothing in sections 20-570 to 20-630, inclusive, shall be construed to prohibit the sale of veterinary drugs that are nonlegend drugs by any person who holds a permit to sell nonlegend drugs.(P.A. 95-264, S. 44; P.A. 99-175, S. 43.)History: P.A. 99-175 replaced reference to Sec. 20-624 with reference to Sec. 20-630.
CT Gen Stat § 20-626 (2020)
2020 Connecticut General Statutes|Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards|Chapter 400j - Pharmacy|Section 20-626 - Confidentiality of pharmacy records.

 (a) No pharmacist or pharmacy shall reveal any records or information concerning the nature of pharmaceutical services rendered to a patient without the oral or written consent of the patient or the patient's agent. If a patient or a patient's agent gives oral consent to release records or information, the pharmacist shall promptly record, in writing or in electronic data base form, the oral consent by listing the patient's name, the name of the patient's agent, if applicable, the date and the nature of the records or information released.(b) Notwithstanding subsection (a) of this section, a pharmacist or pharmacy may provide pharmacy records or information to the following: (1) The patient; (2) the prescribing practitioner or a pharmacist or another prescribing practitioner presently treating the patient when deemed medically appropriate; (3) a person registered or licensed pursuant to chapter 378 who is acting as an agent for a prescribing practitioner that is presently treating the patient or a person registered or licensed pursuant to chapter 378 providing care to the patient in a hospital; (4) third party payors who pay claims for pharmaceutical services rendered to a patient or who have a formal agreement or contract to audit any records or information in connection with such claims; (5) any governmental agency with statutory authority to review or obtain such information; (6) any individual, the state or federal government or any agency thereof or court pursuant to a subpoena; and (7) any individual, corporation, partnership or other legal entity which has a written agreement with a pharmacy to access the pharmacy's database provided the information accessed is limited to data which does not identify specific individuals.(P.A. 95-85; P.A. 99-175, S. 44.)History: P.A. 99-175 amended Subsec. (b) to make technical changes.Subsec. (a):Statute is intended to protect information concerning the nature of customer's treatment and not pharmacy's billing practices. 53 CA 129.Subsec. (b):Pharmacy required to comply with investigative demand of commissioner; civil investigative demand determined to be equivalent of subpoena. 53 CA 129.